Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...
Vicentra BV aims to make its Kaleido 2 insulin patch pump and automated insulin delivery system even smaller than its current device, already amongst the smallest, lightest and most precise insulin ...
A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...
Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...
A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...
Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...
Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...
The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this. Whatever happens, though ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...
3d
Zacks Investment Research on MSNTNDM Stock Gains on the Commercial Launch of Control-IQ+ TechnologyTandem Diabetes Care, Inc. TNDM recently commercially launched Control-IQ+ technology - the latest generation of its advanced hybrid closed-loop algorithm in the United States. Control-IQ+ is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results